Brenda Libby Coleman

Array ( [id] => 5801423 [patent_doc_number] => 20060035887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Process for preparing olanzapine' [patent_app_type] => utility [patent_app_number] => 11/171093 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2065 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035887.pdf [firstpage_image] =>[orig_patent_app_number] => 11171093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112022 [patent_doc_number] => 07718647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Substituted azepine derivatives as serotonin receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/170266 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23989 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718647.pdf [firstpage_image] =>[orig_patent_app_number] => 11170266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860345 [patent_doc_number] => 20080269195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine' [patent_app_type] => utility [patent_app_number] => 11/571051 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17164 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269195.pdf [firstpage_image] =>[orig_patent_app_number] => 11571051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739054 [patent_doc_number] => 20060009445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Tumor-inhibiting anellated azepinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/165153 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7119 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009445.pdf [firstpage_image] =>[orig_patent_app_number] => 11165153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247861 [patent_doc_number] => 20070244095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Compounds and Method for Treating Dyslipidemia' [patent_app_type] => utility [patent_app_number] => 11/570542 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67425 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244095.pdf [firstpage_image] =>[orig_patent_app_number] => 11570542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152273 [patent_doc_number] => 07678902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)dibenzo[b,f][1,4]thiazepine' [patent_app_type] => utility [patent_app_number] => 11/571116 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3671 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678902.pdf [firstpage_image] =>[orig_patent_app_number] => 11571116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624342 [patent_doc_number] => 08003638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => '7-pyrazolylbenzazepines having affinity for D3 receptor' [patent_app_type] => utility [patent_app_number] => 11/570623 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10976 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003638.pdf [firstpage_image] =>[orig_patent_app_number] => 11570623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691443 [patent_doc_number] => 20070232590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => '3-Cylcoalkylbenzazepines as Histamine H3 Antagonists' [patent_app_type] => utility [patent_app_number] => 11/570383 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11579 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232590.pdf [firstpage_image] =>[orig_patent_app_number] => 11570383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233522 [patent_doc_number] => 20050256104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/152745 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91447 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256104.pdf [firstpage_image] =>[orig_patent_app_number] => 11152745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613225 [patent_doc_number] => 07989444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Compounds having affinity for dopamine D3 receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/569880 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31734 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989444.pdf [firstpage_image] =>[orig_patent_app_number] => 11569880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101816 [patent_doc_number] => 20070185078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Substituted triazole derivatives as oxytocin antagonists' [patent_app_type] => utility [patent_app_number] => 11/570199 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19884 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185078.pdf [firstpage_image] =>[orig_patent_app_number] => 11570199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625916 [patent_doc_number] => 20060264421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Conversion process for 2,3-benzodiazepine enantiomers' [patent_app_type] => utility [patent_app_number] => 11/135100 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3586 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264421.pdf [firstpage_image] =>[orig_patent_app_number] => 11135100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085903 [patent_doc_number] => 20070275954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Novel Fused Heterocycles and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/569112 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44266 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275954.pdf [firstpage_image] =>[orig_patent_app_number] => 11569112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226638 [patent_doc_number] => 20050261494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Process for synthesis of dinitrotetraoxadiazaisowurzitane (DTIW)' [patent_app_type] => utility [patent_app_number] => 11/131288 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5426 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261494.pdf [firstpage_image] =>[orig_patent_app_number] => 11131288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 260058 [patent_doc_number] => 07572784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Compounds and methods for inhibiting mitotic progression' [patent_app_type] => utility [patent_app_number] => 11/127855 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46565 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572784.pdf [firstpage_image] =>[orig_patent_app_number] => 11127855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111761 [patent_doc_number] => 20050209217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => '3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/124278 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23532 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209217.pdf [firstpage_image] =>[orig_patent_app_number] => 11124278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250616 [patent_doc_number] => 20050272735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => '1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/123219 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28743 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272735.pdf [firstpage_image] =>[orig_patent_app_number] => 11123219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112715 [patent_doc_number] => 07713956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity' [patent_app_type] => utility [patent_app_number] => 11/579806 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5514 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713956.pdf [firstpage_image] =>[orig_patent_app_number] => 11579806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112355 [patent_doc_number] => 20070196270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Compounds As Ccri Antagonists' [patent_app_type] => utility [patent_app_number] => 10/599819 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60460 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196270.pdf [firstpage_image] =>[orig_patent_app_number] => 10599819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912940 [patent_doc_number] => 20050176698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Neuropeptide Y antagonists' [patent_app_type] => utility [patent_app_number] => 11/100938 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13932 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176698.pdf [firstpage_image] =>[orig_patent_app_number] => 11100938 [rel_patent_id] =>[rel_patent_doc_number] =>)